Add to ORKGZonisamide was used as an add-on drug in 25 non-obese patients with drug resistant epilepsy. After 3-month follow-up patients had seizures' reduction and the body weight was apparently unchanged. We also found a decrease of the anxiety levels and an increase of Quality of Life values. Our data are preliminary; we have to complete our protocol to confirm these findings
AbstractEuropean clinical trials of zonisamide as adjunctive therapy for refractory partial seizures...
Abstract: this article represents review of literature devoted to a new antiepileptic drug Zonegran ...
OBJECTIVE: Traditional pharmacotherapy has undoubtedly improved the outcome of patients with psychia...
Zonisamide was used as an add-on drug in 25 non-obese patients with drug resistant epilepsy. After 3...
Compared with placebo, for people (mostly adolescents and adults) with focal epilepsy uncontrolled b...
Antiepileptic drugs that can reduce aberrant metabolism are beneficial for patients. Zonisamide (ZNS...
Zonisamide has been associated with weight loss in children and adults.status: publishe
none13PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on dr...
Zonisamide is a benzisoxazole derivative, chemically unrelated to other antiepileptic drugs, that ap...
Marco MulaDivision of Neurology, Trinity Hospital, Borgomanero, ItalyAbstract: Epilepsy is one of th...
Objective To evaluate the efficacy and safety of zonisamide (ZNS) as adjunctive therapy in patients ...
Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placeb...
Zonisamide – a new generation antiepileptic drug – features a multidirectional mechanism of action. ...
AbstractPurposeZonisamide is licensed for adjunctive therapy for partial-onset seizures with or with...
PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on drug fo...
AbstractEuropean clinical trials of zonisamide as adjunctive therapy for refractory partial seizures...
Abstract: this article represents review of literature devoted to a new antiepileptic drug Zonegran ...
OBJECTIVE: Traditional pharmacotherapy has undoubtedly improved the outcome of patients with psychia...
Zonisamide was used as an add-on drug in 25 non-obese patients with drug resistant epilepsy. After 3...
Compared with placebo, for people (mostly adolescents and adults) with focal epilepsy uncontrolled b...
Antiepileptic drugs that can reduce aberrant metabolism are beneficial for patients. Zonisamide (ZNS...
Zonisamide has been associated with weight loss in children and adults.status: publishe
none13PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on dr...
Zonisamide is a benzisoxazole derivative, chemically unrelated to other antiepileptic drugs, that ap...
Marco MulaDivision of Neurology, Trinity Hospital, Borgomanero, ItalyAbstract: Epilepsy is one of th...
Objective To evaluate the efficacy and safety of zonisamide (ZNS) as adjunctive therapy in patients ...
Zonisamide (ZNS) efficacy and safety in epilepsy have been demonstrated in four double-blind, placeb...
Zonisamide – a new generation antiepileptic drug – features a multidirectional mechanism of action. ...
AbstractPurposeZonisamide is licensed for adjunctive therapy for partial-onset seizures with or with...
PURPOSE: To report on the first multicenter Italian experience with zonisamide as an add-on drug fo...
AbstractEuropean clinical trials of zonisamide as adjunctive therapy for refractory partial seizures...
Abstract: this article represents review of literature devoted to a new antiepileptic drug Zonegran ...
OBJECTIVE: Traditional pharmacotherapy has undoubtedly improved the outcome of patients with psychia...